Lexicon Pharmaceuticals (LXRX) Q4 2023 Earnings

11MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.22
-0.2
-0.19
-0.17

Details

Expected EPS
-0.217168
Actual EPS
-0.2
Surprise EPS
0.02
Surprise Percent
+7.91%

Description

Lexicon Pharmaceuticals (LXRX) has reported earnings of -0.2 per share for Q4 2023.

0 Comments

Share your thoughts